CARM icon

Carisma Therapeutics
CARM

Overview Fund Activity

36 hedge funds and large institutions have $9.47M invested in Carisma Therapeutics in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 15 closing their positions.

Holders
36
Holders Change
-11
Holders Change %
-23.4%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
13
Reduced
6
Closed
15
Calls
$826K
Puts
$173K
Net Calls
+$653K
Net Calls Change
-$864K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$117K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$411K
3
Northern Trust
3
Northern Trust
Illinois
$125K
4
Victory Capital Management
4
Victory Capital Management
Texas
$18K
5
UBS Group
5
UBS Group
Switzerland
$15K

Top Sellers

1
Qube Research & Technologies (QRT)
1
Qube Research & Technologies (QRT)
United Kingdom
$0
2
CS
2
Credit Suisse
Switzerland
$0
3
HP
3
Hikari Power
Japan
$0
4
OAM
4
Oxford Asset Management
United Kingdom
$0
5
ECM
5
ExodusPoint Capital Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Citigroup
51
Citigroup
New York
$0 500 – –
CFGS
52
Concourse Financial Group Securities
Alabama
– – – –
Wells Fargo
53
Wells Fargo
California
$0 1,501 +636 +74%
1 2
3